Wave Life Sciences targets fat loss without sacrificing muscle

Wave Life Sciences has moved its next-gen obesity therapy into Phase 2, aiming to tackle one of weight loss medicine’s biggest challenges. The obesity drug race has largely been defined by one question: how much weight can people lose? But a growing number of researchers are asking a different one: what kind of weight are […] The post Wave Life Sciences targets fat loss without sacrificing muscle appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.